SETD2 and nonpapillary renal cell carcinoma: In this study, we present a unique perspective of SETD2 deficient ccRCC by not only mapping the transcriptome and epigenome changes resulting from SETD2/H3K36me3 loss, but also integrating effects of SETD2 status on the m6A epitranscriptome.